Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes

Major Depressive Episodes (MDE) following COVID-19 are frequent, can have a characteristic clinical picture, and are associated with immune-inflammatory changes. Vortioxetine is known to improve physical and cognitive performance in patients with depression and shows anti-inflammatory and anti-oxida...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Nicola, Marco, Pepe, Maria, Montanari, Silvia, Spera, Maria Chiara, Panaccione, Isabella, Simonetti, Alessio, Sani, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and ECNP. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905099/
https://www.ncbi.nlm.nih.gov/pubmed/36808043
http://dx.doi.org/10.1016/j.euroneuro.2023.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905099/
https://www.ncbi.nlm.nih.gov/pubmed/36808043
http://dx.doi.org/10.1016/j.euroneuro.2023.02.006

Ejemplares similares